CCDC69 activators encompass a diverse array of chemicals that modulate intracellular signaling pathways leading to its activation. One primary mode of action involves the elevation of intracellular second messengers such as cAMP. This elevation is achieved through the direct stimulation of adenylyl cyclase or the inhibition of phosphodiesterases, thereby preventing the breakdown of cAMP within the cell. The elevated levels of cAMP activate protein kinase A and other cAMP-dependent proteins, which could phosphorylate and enhance the activity of CCDC69. Additionally, certain activators work by modulating intracellular calcium levels, either through direct ionophoretic mechanisms or by modulating the function of calcium channels. This modulation of calcium signaling is critical, as it triggers a cascade of events that could lead to the phosphorylation and activation of CCDC69 by calcium-dependent kinases.
Another set of activators influences the activity of CCDC69 by interacting with specific enzymes involved in signal transduction. For example, certain activators inhibit protein kinase A, which may lead to compensatory cellular responses that result in the activation of CCDC69. Others inhibit glycogen synthase kinase-3 or activate protein kinase C, potentially leading to an environment conducive to the phosphorylation and subsequent activation of CCDC69. Additionally, the incorporation of fatty acids into cell membranes may alter the membrane's properties, which influences signal transduction pathways and potentially activates CCDC69.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Directly stimulates adenylyl cyclase, increasing cAMP levels that may enhance the activity of CCDC69 through cAMP-dependent pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, elevating cAMP and cGMP levels, potentially leading to the activation of CCDC69 via secondary messenger pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C, which could then phosphorylate and activate CCDC69 if it is a substrate for PKC. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Increases intracellular calcium, thereby possibly activating CCDC69 through calcium-dependent signaling pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Ionophore that raises intracellular calcium levels and may activate CCDC69 through calcium-mediated signaling. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Cell-permeable cAMP analog that activates cAMP-dependent pathways, possibly leading to the activation of CCDC69. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $102.00 $423.00 | ||
Omega-3 fatty acid which can be incorporated into cell membranes and may modulate signal transduction pathways involved in CCDC69 activation. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $92.00 $182.00 | 71 | |
Protein kinase A inhibitor that could indirectly lead to activation of CCDC69 through compensatory mechanisms within the PKA signaling pathway. | ||||||
Lanthanum(III) chloride | 10099-58-8 | sc-257661 | 10 g | $88.00 | ||
Blocks calcium channels, indirectly affecting calcium signaling pathways that could lead to the activation of CCDC69. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits glycogen synthase kinase-3, possibly leading to the activation of signaling pathways that involve CCDC69. |